KRAS and non-small cell lung carcinoma: MKRN3 is frequently mutated in non–small-cell lung cancers (NSCLCs), and genomic aberrations of MKRN3 are found to be enriched in NSCLC samples harboring KRAS mutations (Li et al., 2021).